Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
518 studies found for:    "Hepatitis B, Chronic"
Show Display Options
Rank Status Study
21 Active, not recruiting Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: REP 2139-Ca;   Drug: pegylated interferon;   Drug: entecavir
22 Completed A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a [Pegasys]
23 Unknown  Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: interferon α plus nucleoside analogue;   Drug: interferon α
24 Completed Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention:
25 Completed An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)
Condition: Hepatitis B, Chronic
Intervention: Drug: Adefor dipivoxil
26 Terminated Study of ARC-520 in Patients With Chronic Hepatitis B Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: ARC-520;   Drug: Placebo
27 Completed
Has Results
An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a [Pegasys]
28 Active, not recruiting
Has Results
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Condition: Hepatitis B, Chronic
Intervention: Drug: Entecavir
29 Not yet recruiting Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Interventions: Drug: DA-2802;   Drug: Viread®
30 Completed A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
31 Completed A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
32 Completed
Has Results
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a [Pegasys]
33 Recruiting An Open-Label, Multicenter, National Observational Study in Patients With Chronic Hepatitis B Receiving Therapy With PEGASYS (Peginterferon Alfa-2a 40kD) - The PRO B Study
Condition: Hepatitis B, Chronic
Intervention:
34 Completed An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)
Condition: Hepatitis B, Chronic
Intervention:
35 Terminated A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a (40KD) [PEGASYS]
36 Completed
Has Results
A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
37 Completed
Has Results
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Condition: Hepatitis B, Chronic
Intervention:
38 Active, not recruiting An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention:
39 Completed
Has Results
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Entecavir + Tenofovir
40 Active, not recruiting
Has Results
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a [Pegasys]

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.